MedTrace Logo

Epidemiology and Current Practices in Severe Community-Acquired Pneumonia

NCT07301099 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2588

Last updated 2026-01-15

No results posted yet for this study

Summary

The goal of this observational study is to learn more about severe community-acquired pneumonia (sCAP) in adults who need hospital or intensive care. This type of pneumonia starts outside the hospital and can quickly become life-threatening. The study aims to understand how people with sCAP are cared for in different parts of the world and how these differences relate to their recovery.

* The main questions this study aims to answer are:
* What are the characteristics, treatments, and outcomes of adults with sCAP?
* How closely do hospitals follow international guidelines for diagnosing and treating sCAP?
* What factors are linked to worse outcomes, such as the need for a ventilator or risk of death?

This study will not test any new drugs or procedures. Instead, researchers will observe the care that participants already receive as part of their normal treatment. Hospitals in many countries will take part, including centres in Europe, North America, Latin America, Asia, Africa, and Oceania. This global participation will help show how sCAP affects people in different health systems and communities.

Participants will be adults who arrive at a hospital or intensive care unit with severe pneumonia. Most information will come from medical records, such as symptoms, test results, treatments given, and how participants respond to care. In some hospitals with special laboratory capacity, additional blood or breathing samples may be collected to study how the body fights infection.

No extra visits are required for routine data-only participants. In sites that collect samples, these will usually be taken at the same time as routine medical care to avoid extra procedures. Researchers will also ask about recovery after hospital discharge at 60 days, 6 months, and 12 months. These follow-ups will help us understand long-term health, complications, and quality of life after sCAP.

By collecting information from a large number of hospitals around the world, this study hopes to identify patterns that can help improve diagnosis, treatment, and survival for people with severe pneumonia. The findings may also help health care teams and public health leaders update treatment guidelines and strengthen care for future patients.

Conditions

  • Severe Community-acquired Pneumonia (sCAP)

Sponsors & Collaborators

  • International Severe Acute Respiratory and Emerging Infection Consortium

    collaborator OTHER

  • European Society of Intensive Care Medicine

    collaborator OTHER

  • Latin American Intensive Care Network (LIVEN)

    collaborator UNKNOWN

  • Universidad de la Sabana

    lead OTHER

Principal Investigators

  • Luis Felipe Reyes, MD, MSc, PhD · Universidad de la Sabana

  • Ignacio-Martin Loeches, MD, PhD, FJFICMI · St James's Hospital, Trinity College Dublin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2027-02-01
Completion
2027-08-31

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07301099 on ClinicalTrials.gov